Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia (original) (raw)
References
American Academy of Neurology AIDS Taskforce (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41: 778–785 Google Scholar
Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive peptide. Nature 335: 639–642 Google Scholar
Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D, Epstein LG, Esiri MM, Giangaspero F, Gosztonyi G, Gray F, Griffin JW, Henin D, Iwasaki Y, Janssen RS, Johnson RT, Lantos PL, Lyman WD, McArthur JC, Nagashima K, Peress N, Petito CK, Price RW, Rhodes RH, Rosenblum M, Said G, Scaravilli F, Sharer LR, Vinters HV (1991) HIV-associated disease of the nervous system and proposal for neuropathology-based terminology. Brain Pathol 1: 143–152 Google Scholar
Ciardi A, Sinclair E, Scaravilli F, Harcourt-Webster NJ, Lucas S (1990) The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study. Acta Neuropathol 81: 51–59 Google Scholar
Davies J, Everall I, Bell J, Esiri M, Lucas S, Harrison M, Scaravilli F, Lantos P (1993) Does azidothymidine after HIV-associated neuropathology. Clin Neuropathol 12: S9
Dreyer EB, Kaiser PK, Offermann JT, Lipton SA (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364–367 Google Scholar
Everall IP, Luthert PJ, Lantos PL (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119–1121 Google Scholar
Everall IP, Luthert PJ, Lantos PL (1993) Neuronal number and volume alterations in the neocortex in HIV-infected individuals. J Neurol Neurosurg Psychiatry 56: 481–486 Google Scholar
Everall I, Barnes H, Spargo E, Lantos P (1993) Evidence for selective neuronal loss in the putamen in HIV-infected patients using spatial analysis. Clin Neuropathol 12: S10
Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14: 60–67 Google Scholar
Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993) Clinical-neuropathologic correlation in HIV associated dementia. Neurology 43: 2230–2237 Google Scholar
Grauss F, Ribalta T, Abos J, Alom J, Cruz-Sanchez F, Mallolas J, Miro M, Cardesa A, Tolosa E (1990) Subacute cerebellar syndrome as the first manifestation of AIDS dementia complex. Acta Neurol Scand 81: 118–120 Google Scholar
Gray F, Geny C, Dournon E, Fenelon G, Lionnet F, Gherardi R (1991) Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain. Lancet 337: 852–853 Google Scholar
Gundersen HJG (1986) Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc 143: 3–45 Google Scholar
Gundersen HJG (1988) The nucleator. J Microsc 138: 291–310 Google Scholar
Gundersen HJG, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Acta Pathol Microbiol Immunol Scand 96: 857–881 Google Scholar
Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mourdain MM, Sadler AE, Kelip J, Rubinow D, Markey SP (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29: 202–209 Google Scholar
Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE (1993) HIV envelope protein-induced neuronal damage and retardation of behavioural development in rat neonates. Brain Res 603: 222–233 Google Scholar
Ketzler S, Weis S, Haug H, Budka H (1990) Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 80: 92–94 Google Scholar
Lipton SA (1991) HIV-related neurotoxicity. Brain Pathol 1: 193–199 Google Scholar
Maehlen J, Dunlop O, Dobloug JH, Liestol K, Torvik A (1993) Brain lesions in AIDS patients in Norway 1983–1992. Unexplained changes with time and opposing effects of length of survival and AZT treatment. Clin Neuropathol 12: S12
Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA (1992) Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32: 321–329 Google Scholar
Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA (1992) Selective neuronal vulnerabiluty in HIV encephalitis. J Neuropathol Exp Neurol 51: 585–593 Google Scholar
Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA (1992) Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 66: 285–291 Google Scholar
McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NMH, McArthur JH, Selnes OA, Jacobsen LP, Visscher BR, Concha M, Saah A (1993) Dementia in AIDS patients. Neurology 43: 2245–2252 Google Scholar
Merrill JE, Koyanagi JZ, Thomas L, Martin F, Chen ISY (1992) Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 66: 2217–2225 Google Scholar
Navia BA, Jordan BD, Price RW (1986) The AIDS-dementia complex. I. Clinical features. Ann Neurol 19: 517–524 Google Scholar
Navia BA, Cho E-S, Petito CK, Price RW (1986) The AIDS-dementia complex. II. Neuropathology. Ann Neurol 19: 525–535 Google Scholar
Price RW, Brew BJ (1988) The AIDS dementia complex. J Infect Dis 158: 1079–1083 Google Scholar
Pulliam L, Herndier BG, Tang NM, McGrath MS (1991) Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neutrochemical alterations in cultured human brains. J Clin Invest 87: 503–512 Google Scholar
Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R (1991) Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 82: 39–44 Google Scholar
Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL (1988) Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319: 889–896 Google Scholar
Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MJ, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Koch MA, Feinberg J, Dafni O (1993) Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial. Ann Neurol 33: 343–349 Google Scholar
Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134: 127–136 Google Scholar
Swingler S, Easton A, Morris A (1992) Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells. AIDS Res Hum Retroviruses 8: 487–493 Google Scholar
Tornatore C, Nath A, Amemiya K, Major EO (1991) Persistent human immunodeficiency virus type-1 infection in human fetal glial cells reactivated by T-cell factors or by cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65: 6094–6100 Google Scholar
Tyor WR, Glass JD, Griffin JW, Becker SP, McArthur JC, Bezman L, Griffen DE (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31: 349–360 Google Scholar
Weis S, Haug H, Budka H (1993) Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta neuropathol 85: 185–189 Google Scholar
Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991) Neocortocal damage during HIV infection. Ann Neurol 29: 651–657 Google Scholar
Williams RW, Rakic P (1988) Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol 278: 344–352 Google Scholar
Yarchoan R, Brouwers P, Spitzer AR, Grafman J, Safai B, Perno CF, Larson SM, Berg G, Fischl MA, Wichman A, Thoman RV, Brunetti A, Schmidt PJ, Myers CE, Broder S (1987) Response of human immunodeficiency virus associated neurological disease to 3‘-azido-3’-deoxythymidine. Lancet I: 132–135 Google Scholar